We are proudly a Ukrainian website. Our country was attacked by Russian Armed Forces on Feb. 24, 2022.
You can support the Ukrainian Army by following the link: https://u24.gov.ua/.
Even the smallest donation is hugely appreciated!
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hepato-biliary and pancreatic diseases.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Topala, M., V. Ionescu, A. Ion, R. Neamtu, S. Dragan, and C. Gheorghe. "P343 Pancreato-biliary disorders in patients with inflammatory bowel diseases – a single-centre report." Journal of Crohn's and Colitis 18, Supplement_1 (January 1, 2024): i738. http://dx.doi.org/10.1093/ecco-jcc/jjad212.0473.
Abstract Background Inflammatory bowel diseases (IBD) are regarded as multisystemic disorders due to the high prevalence of extraintestinal symptoms. Hepato-pancreato-biliary involvement can be present in up to 50% of patients, due to IBD extraintestinal manifestations and complications. Our aim was to evaluate the prevalence of the pancreato-biliary diseases in patients diagnosed with IBD. Methods We conducted a single-centre retrospective study which included patients diagnosed with Crohn’s disease (CD) and ulcerative colitis (UC), admitted between 1 January 2018 and 1 August 2023 in the Gastroenterology and Surgery Departments of the Fundeni Clinical Institute (Romania). We analysed the medical history (including abdominal imaging - ultrasound, computed tomography or magnetic resonance imaging) of patients during hospital follow-up and we screened for pancreato-biliary disorders. Results We analysed 1736 patients, of which 303 patients (17%) associated pancreato-biliary involvement and 756 patients (44%) had no pancreato-biliary disorders, with both subgroups having at least one abdominal imaging scan during follow-up; 677 patients (39%) had neither history of pancreato-biliary disorders, nor abdominal imaging. 30 patients (1.72% of total; 56.6% CD, 77% male) had acute pancreatitis (93.3% mild), 66.67% being drug-induced (13 cases - azathioprine, six cases - 5-amynosalicilates, one case - metronidazole). Three patients were diagnosed with idiopathic chronic pancreatitis and one with type 2 autoimmune pancreatitis. In the subgroup that underwent abdominal imaging (1059 patients) we identified 124 patients (11.70%) with pancreatic steatosis, 11 patients (1.03%) with pancreatic cysts (one case of intraductal papillary mucinous neoplasm) and three patients (0.28%) with congenital pancreatic anomalies (two annular pancreases, one pancreas divisum). There were no patients diagnosed with pancreatic adenocarcinoma. We identified 14 patients (0.8% from total; 64.28% UC, 57.14% male) with primary sclerosing cholangitis, of which five underwent liver transplantation, one case of primary biliary cholangitis and three cases of cholangiocarcinoma. The subgroup with abdominal imaging included 46 patients (4.34%) with prior cholecystectomy and 147 patients (13.88%) with gallbladder lithiasis or sludge (59.86% CD; 53.06% male; 39.45% intestinal resection). Conclusion Up to one third of patients with IBD that underwent abdominal imaging associated pancreato-biliary involvement. The high risk of drug-induced acute pancreatitis in IBD has to be taken into consideration. Screening for possible extraintestinal manifestations and early diagnosis of extraintestinal complications might improve the IBD management.
3
Anand, Madhur, Noor Topno, Ranendra Hajong, Anoop J. Baruah, Donkupar Khongwar, and Swati Agarwal. "Surgical manifestations and management of gastrointestinal and hepato-pancreato-biliary ascariasis: an observational study." International Surgery Journal 7, no. 11 (October 23, 2020): 3620. http://dx.doi.org/10.18203/2349-2902.isj20204660.
Background: Ascaris lumbricoides is the largest intestinal nematode parasite of humans. This study describes different presentations and management patterns of gastrointestinal and hepato-pancreato-biliary ascariasis presenting to a tertiary centre of North-eastern India.Methods: This was a prospective observational study aimed to study the presentations and management patterns of Ascaris related surgical diseases including intestinal obstruction, pancreatitis and cholangitis in a tertiary centre of Northeast India. All consenting cases of gastrointestinal and hepato-pancreato- biliary ascariasis admitted in our hospital were included.Results: Ninty patients with Ascaris sequeale were included, which included biliary ascariasis without cholangitis: 36, pancreatitis: 30, cholangitis: 18 and sub-acute intestinal obstruction: 6. Ultrasound was the most useful diagnostic investigation followed by stool examination and endoscopy. Hepato-pancreato-biliary ascariasis was managed conservatively and the progress monitored with sonography. The surgical management choledocho-duodenostomy was done for three patients having biliary ascariasis with unresolving obstructive jaundice and recurrent cholangitis on conservative management and 6 patients underwent therapeutic endoscopic worm removal. There were no deaths. No patient needed ICU care.Conclusions: Sonography can be helpful in diagnosing the presence of worms, its complications and in evaluating response to treatment. Hepato-pancreato-biliary ascariasis can be managed conservatively for majority of the patients.
4
Di Vincenzo, Federica, Alberto Nicoletti, Marcantonio Negri, Federica Vitale, Lorenzo Zileri Dal Verme, Antonio Gasbarrini, Francesca Romana Ponziani, and Lucia Cerrito. "Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders." Antibiotics 12, no. 6 (June 17, 2023): 1068. http://dx.doi.org/10.3390/antibiotics12061068.
The gut microbiota is a pivotal actor in the maintenance of the balance in the complex interconnections of hepato-biliary-pancreatic system. It has both metabolic and immunologic functions, with an influence on the homeostasis of the whole organism and on the pathogenesis of a wide range of diseases, from non-neoplastic ones to tumorigenesis. The continuous bidirectional metabolic communication between gut and hepato-pancreatic district, through bile ducts and portal vein, leads to a continuous interaction with translocated bacteria and their products. Chronic liver disease and pancreatic disorders can lead to reduced intestinal motility, decreased bile acid synthesis and intestinal immune dysfunction, determining a compositional and functional imbalance in gut microbiota (dysbiosis), with potentially harmful consequences on the host’s health. The modulation of the gut microbiota by antibiotics represents a pioneering challenge with striking future therapeutic opportunities, even in non-infectious diseases. In this setting, antibiotics are aimed at harmonizing gut microbial function and, sometimes, composition. A more targeted and specific approach should be the goal to pursue in the future, tailoring the treatment according to the type of microbiota modulation to be achieved and using combined strategies.
5
Amin, Arshad, Faiz Ur Rahman, Fazli Junaid, and Shahid Nisar. "Pattern of Surgical Cases and its Management in Bacha Khan Medical Complex Shahmansoor Swabi." Journal of Gandhara Medical and Dental Science 4, no. 1 (September 1, 2017): 8–12. http://dx.doi.org/10.37762/jgmds.4-1.26.
OBJECTIVETo study the pattern of general surgery cases and their management in Bacha Khan Medical Complex Shahmansoor Swabi.METHODSThis descriptive cases-series study was conducted prospectively in general surgery department Bacha Khan Medical Complex Shahmansoor Swabi form jan, 2013 to Dec, 2015. There were 1200 patients in the series who were managed either conservatively or operated upon. All patients with symptoms suggesting a surgical disease and managed as a surgical case were included, while cases that were referred to other departments and those that left against medical advice were excluded.RESULTSMost of the patients had alimentary tract diseases 361(30%) followed by urinary tract diseases 264 (22%),superficial lumps 142 (11.8%), hernia 140 (11.7%), hepato-biliary-pancreatic diseases 116 (9.7%), breast diseases 55 (4.6%), scrotal diseases 41 (3.4%), thyroid diseases 28 (2.3%),salivary gland diseases 15 (1.3%), vascular diseases 8 (0.7%), thoracic diseases 2 (0.2%) and miscellaneous 28 (2.3%). A total of 604 (64.5%) patients were treated as elective cases and333 (35.5%). were treated as emergency cases. As many as 937 (74.08%) patient were treated by operations and 263 (21.92%) patients by conservative treatment, while 41 (3.41%) patients were referred. Seven patients expired, giving a mortality rate of 0.58%.CONCLUSIONThe commonest cause of seeking surgical care was alimentary tract diseases, followed by urinary tract diseases, superficial lumps, hernias, hepato-biliary-pancreatic diseases, breast diseases, scrotal diseases and thyroid diseases. Bacha Khan Medical Complex Shahmansoor Swabi is a newly established hospital catering to the needs of population of district Swabi and adjoining districts and areas.
6
De, Uptal, M. Mukherjee, S. Das, and Rupesh Kumar. "Hepato-pancreatic ascariasis." Tropical Doctor 40, no. 4 (September 16, 2010): 227–29. http://dx.doi.org/10.1258/td.2010.090368.
Shapey, Iestyn M., and Mustafa Sultan. "Machine learning for prediction of postoperative complications after hepato-biliary and pancreatic surgery." Artificial Intelligence Surgery 3, no. 1 (2023): 1–13. http://dx.doi.org/10.20517/ais.2022.31.
Machine Learning (ML) relates to the use of computer-derived algorithms and systems to enhance knowledge in order to facilitate decision making. In surgery, ML has the potential to shape clinical decision making and the management of postoperative complications in three ways: (a) by using the predicted probability of postoperative complications or survival to determine and guide optimal treatment; (b) by identifying anomalous data and patterns representing high-risk physiological states during the perioperative period and taking measures to minimise the impact of the existing risks; (c) to facilitate post-hoc identification of physiological trends, phenotypic patient characteristics, morphological characteristics of diseases, and human factors that may help alert surgeons to relevant risk factors in future patients. The accuracy, validity and integrity of data that are input into ML predictive models are central to its future success. ML could reduce errors by drawing attention to known risks of complications through supervised learning, and gain greater insights by identifying previously under-appreciated aspects of care through unsupervised learning. The success of ML in enhancing patient care will be determined by the human potential to incorporate data science techniques into daily clinical practice.
8
Faisal, Shah, Muhammad Imranullah, Muhammad Qammar Noshad, Arjan Kumar, Talha Rehman, and Ulas Khan. "Patients' Prognosis in a Pakistani Hepato-Biliary Unit Treating Acute Severe Necrotizing Pancreatitis." Pakistan Journal of Medical and Health Sciences 16, no. 5 (May 30, 2022): 1588–90. http://dx.doi.org/10.53350/pjmhs221651588.
Objective: The outcomes of individuals who were admitted to a hepatobiliary unit suffering from acute severe necrotizing pancreatitis will be the focus of this research. Study Design: Observational/ Prospective study Place and Duration: Conducted at Department of Gastroenterology Hayatabad Medical Complex Peshawar, during from the period Jan, 2021 to June, 2021. Methods: There were 85 patients of both genders were presented in this study. Included patients were aged between 20-70 years. All the patients had severe necrotizing pancreatitis were included. Detailed demographics of enrolled cases included age,sex, body mass index, etiology and comorbidities were recorded after taking informed written consent. Outcomes were calculated in terms of complications, hospital stay, number of drains inserted and nutritional support among all cases. SPSS 22.0 was used to analyze all data. Results: Among 85 patients, majority of the cases were males 62 (72.9%) and the rest of the patients were females 23 (27.1%). Included patients had mean age 47.12±8.39 years and had mean BMI 26.2±6.25 kg/m2. Most common comorbidity was diabetes mellitus found in 18 (21.2%),followed by hypertension in 17 (20%) and ischemic heart disease in 9 (10.6%) cases. Gall stones were the most common etiology found in 35 (41.2%) followed by idiopathic in 16 (18.8%) and cigarette smoking in 13 (15.3%) patients. NG feed was the most common nutrition in 19 (22.4%) cases. 10 was the most common CTSI score in 43 (50.6%) cases. Mean hospital stay was 31.9±11.82 days and infected necrosis / peri-pancreatic collections was the most common complication.13 (15.3%) cases received EUS drainage and surgical necrosectomy was given to 8 (9.4%) cases. Frequency of deaths was 10 (11.8%). Conclusion: A specialized hepato-biliary unit with a multidisciplinary team approach improves survival with acute severe necrotizing pancreatitis. Percutaneous and EUS-guided draining of pancreatic collections helps prevent necrosectomy for infected pancreatic necrosis. Keywords: Disease outcome, Acute pancreatitis, Infected pancreatic necrosis, Necrosectomy Acute Necrotizing Pancreatitis
9
Campeanu, Ionel. "The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases." Chirurgia 117, no. 4 (2022): 499. http://dx.doi.org/10.21614/chirurgia.2781.
24 Background: Chemotherapy-induced nausea and vomiting (CINV) is well controlled recently thanks to novel antiemetic therapy, but the incidence of nausea remained high in patients receiving either HEC or MEC. The aim of the study is to investigate patterns and severity of CIN in cancer patients who are to receive chemotherapy for the first time. Methods: A nationwide survey on CINV was conducted by the CINV study group of Japan. A 7-day diary for CINV was provided to the patient prior to chemotherapy to record daily occurrence and severity of CINV. CIN was measured using visual analog scales(VAS) of 10cm length scales. Acute and delayed CINV were defined as nausea and vomiting which developed within or after 24 hours after the start of chemotherapy, respectively. Results: A total of 2,068 patients were registered and 1,910 patients were analyzed. A mean age was 62 (range:19-87) and there were 873 males and 1,037 females. MEC was given to 715 as was HEC to 1,195 patients. Underlying diseases were esophageal (192 patients), gastric (152), colorectal (90), hepato-biliary-pancreatic (100), lung (426) and breast cancer (429), and gynecological (214) and hematological malignancy (197). Comparing patients with various cancers treated with similar emetogenic agents or regimens, we easily could find that there are several patterns of CIN severity. Firstly, temporal profiles of CIN severity of esophageal, gastric and lung cancers were similar, having daily increased delayed nausea up to Day 7. The reason of this phenomenon seems due to a single high dose of CDDP. Colorectal and hepato-biliary-pancreatic cancer had a similar mild CIN pattern over 7days, probably due to mild emetogenic nature of oxaliplatin and moderate dose of CDDP. Conclusions: Temporal profile and severity of CIN patterns seem to be divided into several groups and delayed CIN remained to be high and needs further investigation.
Dissertations / Theses on the topic "Hepato-biliary and pancreatic diseases":
1
Giannone, Codiglione Fabio. "Multidisciplinary perioperative strategies for improving short and long-term outcomes in hepato-biliary and pancreatic cancers." Electronic Thesis or Diss., Strasbourg, 2024. http://www.theses.fr/2024STRAJ004.
Cette thèse est une exploration complète de la prise en charge multidisciplinaire des tumeurs hépato-biliopancréatiques (HBP), et de la manière dont cette approche peut améliorer les résultats oncologiques pour le patient. Ce travail est développé en trois chapitres, chacun couvrant un domaine spécifique de cette discipline. Chaque chapitre révèle également une collaboration importante entre chirurgiens, oncologues, chercheurs et diverses personnalités médicales, ouvrant la voie à l'avancement de la prise en charge des tumeurs HBP. Les stratégies de traitement affinées et les approches de médecine personnalisée décrites dans cette thèse ne sont pas des constructions théoriques mais des outils prêts à être intégrés dans les soins aux patients. L'esprit de collaboration soutenu tout au long de ce travail résonne dans l'amélioration des soins aux patients atteints de tumeurs HBP, garantissant que les progrès de la recherche se traduisent par des améliorations cliniques tangibles This thesis is a comprehensive exploration of the multidisciplinary management of hepatobiliarypancreatic tumors (HBP), and how this approach can improve oncological outcomes for the patient.This work is developed in three chapters, each covering a specific domain of this discipline. Each chapter also reveals significant collaboration between surgeons, oncologists, researchers, and various medical personalities, paving the way for the advancement of HBP tumor management. The refined treatment strategies and personalized medicine approaches described in this thesis are not theoretical constructs but tools ready to be integrated into patient care. The spirit of collaboration sustained throughout this work resonates in the improvement of care for patients with HBP tumors, ensuring that research advancements translate into tangible clinical improvements
2
Cherkaoui, Zineb. "Optimisation des parcours de soins des patients complexes en vue d’une prise en charge pour pathologies hépato-bilio-pancréatiques : mise en place du « Diagnostic en un jour », mode d’évaluation et résultats." Electronic Thesis or Diss., Strasbourg, 2023. http://www.theses.fr/2023STRAJ123.
Bien prendre en charge le bon patient au bon moment au bon endroit selon les dernières recommandations des sociétés savantes est aujourd’hui la préoccupation de chaque professionnel de santé dans le but d’améliorer l’état de santé des populations. A travers la mise en place du parcours de soins innovant accéléré «Diagnostic en un jour» pour les pathologies hépato-biliopancréatiques aux Hôpitaux Universitaires de Strasbourg et la réalisation d’une étude comparative au parcours classique avec respectivement 330 vs 152 patients, l’efficacité́ et la soutenabilité́ financière de celui-ci sont prouvées. Nous montrons la possible diffusion de ce modèle à plus grande échelle pour d’autres pathologies et régions. Par ailleurs, la démarche VBHC appliquée à travers les questionnaires standardisés établis pour les cancers du foie et du pancréas permettra le recueil des résultats qui impotent aux patients PROMs et cliniques CROMs ayant pour objectif de tendre vers la pertinence et l’excellence des soins Nowadays, taking good care of the right patient at the right time in the right place according to the latest guidelines established by professional societies is the main concern of each health care provider, aiming to improve populations’ state of health. From the example of the innovative and accelerated care pathway “Oneday diagnosis” for hepatobiliary and pancreatic diseases taking place in Strasbourg university hospital and the comparative study to ordinary pathway with respectively 330 vs 152 patients, we demonstrated its efficiency and sustainability. We confirmed the possible replication elsewhere and for other pathologies. Furthermore, the application of the VBHC concept through standardized questionnaires for liver and pancreatic cancers would allow to collect outcomes that matter to patients PROMs and clinical outcomes CROMs with the objective of reaching relevant and excellent care
3
Norton, Sally A. "The role of endoscopic ultrasound in the evaluation of pancreatic and biliary disease." Thesis, University of Bristol, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.266994.
Ali, A. E. "Studies of pancreatic and biliary physiology in the Syrian golden hamster with particular reference to the aetiology of pancreatic disease." Thesis, University of Manchester, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.233086.
Makuuchi, Masatoshi, Norihiro Kokudo, Irinel Popescu, Jacques Belghiti, Ho-Seong Han, Kyoichi Takaori, and Dan G. Duda, eds. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0063-1.
Poston, Graeme J., R. Adam, and Michael D'Angelica. Surgical management of hepatobiliary and pancreatic disorders. 2nd ed. London: Informa Healthcare, 2011.
Lee, Dong Ki, ed. Advanced ERCP for Complicated and Refractory Biliary and Pancreatic Diseases. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-13-0608-2.
Yamashita, Yasunobu, and Masayuki Kitano. "Endoscopic Ultrasound for Hepato-Pancreato-Biliary Diseases." In The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases, 135–44. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0063-1_16.
Miyasaka, Yoshihiro, and Masafumi Nakamura. "Remnant Pancreatic Cancer After Surgical Resection for Pancreatic Cancer." In The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases, 401–6. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0063-1_54.
Hruban, Ralph H., and Elizabeth Thompson. "Pathology of Pancreatic Cancer." In The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases, 91–97. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0063-1_12.
Perinel, Julie, and Mustapha Adham. "ERAS in Pancreatic Surgery." In The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases, 235–39. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0063-1_29.
Lupescu, Ioana G., and Mugur C. Grasu. "CT in Hepato-Bilio-Pancreatic Surgical Pathology." In The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases, 99–111. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0063-1_13.
Usova, Elena. "Duodenum-Preserving Pancreatic Head Resection." In The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases, 341–46. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0063-1_44.
Dane, Faysal, and Nazim Can Demircan. "Systemic Therapies for Pancreatic Cancer." In The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases, 193–200. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0063-1_23.
Lee, Hee Seung, Seung Woo Park, and Si Young Song. "Chemotherapy in Pancreatic Ductal Adenocarcinoma." In The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases, 171–76. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0063-1_20.
Dioscoridi, Lorenzo, Francesco Pugliese, Edoardo Forti, Alberto Tringali, Marcello Cintolo, Giulia Bonato, and Massimiliano Mutignani. "Biliary and Pancreatic ESWL." In Endotherapy in Biliopancreatic Diseases: ERCP Meets EUS, 203–11. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-42569-2_18.
Conference papers on the topic "Hepato-biliary and pancreatic diseases":
1
Konno, Atsushi, Noriyuki Shido, Kazuya Sase, Xiaoshuai Chen, and Teppei Tsujita. "A Hepato-Biliary-Pancreatic Deformable Model for a Simulation-Based Laparoscopic Surgery Navigation." In 2020 IEEE/SICE International Symposium on System Integration (SII). IEEE, 2020. http://dx.doi.org/10.1109/sii46433.2020.9025967.
Tevethia, Harsh Vardhan, Guresh Kumar, and Shiv Kumar Sarin. "To Evaluate the Efficacy and Safety of Digital Single-Operator Cholangioscopy (DSOC) in Pancreato-Biliary Diseases—One Size Fits All!!!" In ENDOCON 2024. Thieme Medical and Scientific Publishers Pvt. Ltd., 2024. http://dx.doi.org/10.1055/s-0044-1786344.
